Stocktoria

Wellgistics Health, Inc. WGRX

Nasdaq · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2025-02-21

Wellgistics Health, Inc. statistics & valuation

Market cap$9.3M
P / S0.4×
Net margin-433.9%
Net debt$23.4M
Enterprise value USD$32.7M
Return on capital-13800.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-37.80% -433.90% 202320242025
Gross margin (%)
9.70% -27.50% 202320242025
Operating margin (%)
-33.90% -401.70% 202320242025
Return on equity (%)
-101.80% 202320242025
Shares outstanding
44.7M 51.1M 101.3M 202320242025
Net debt ($)
$22.4M $23.4M 202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-855.80% -12.00% -332.50% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
3.47× 202320242025
EPS ($)
-$0.06 -$0.15 -$1.43 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin-27.5%9.7%—
Operating margin-401.7%-33.9%—
Net margin-433.9%-37.8%—
Return on assets-332.5%-12.0%-855.8%
Return on equity813.6%-101.8%99.8%
Debt / equity-1.89×3.47×—
Current ratio0.090.400.12

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.